Viratech Signs Letter of Intent to Provide Social Network for $250,000, Royalties and Equity Interest
STOCKTON, CA, Jan 18, 2013 (MARKETWIRE via COMTEX) --
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech
research social network platform, announced today that it has entered
into a letter of intent to provide a turnkey Social Network for
Wellness Builder, Inc., a company engaged in the development of a
series of nutraceutical products designed to combat the effects of
stress, inadequate nutrition and exposure to environmental toxins.
"As an inventor of Wellness Builder's initial key products, I am
extremely excited that Wellness Builder has engaged Viratech to
provide its Social Network," said CEO Kevin Buckman, MD.
Viratech will provide a turnkey Social Network, using its licensed
patent pending technology platform, which Social Network will act as
an engagement funnel for individual micro social networks within the
Social Network, to obtain and develop user generated content for the
sole purpose of protecting, promoting and producing individual
elements of Wellness Builder's business model. In exchange for the
fully integrated system, Viratech will receive $250,000, a royalty of
5% of the gross sales of all products developed with the use of the
system, and a non-dilutable equity interest of 10% in Wellness
"What made the decision for us to Viratech was simple. Their ability
to convert user generated traffic to develop a contextual based
engagement funnel is one of the smartest technologies I have ever
seen, because this incorporates an integrated approach using a high
powered Social Media Platform," said Fred Schiemann, CEO of Wellness
About Wellness Builder
Our modern lifestyles are characterized by high levels of stress,
inadequate nutrition and exposure to environmental toxins, which can
deplete our bodies of nutrients and make us susceptible to disease.
Wellness Builder applies proven research to formulate natural
products designed to counteract the damage.
Wellness Builder, Inc. is engaged in the research and development of
pharmaceutical and nutraceutical products derived from the research
of Dr. Kevin Buckman. The company has an executive team for funding,
distribution, and marketing of 12 products to sell pharmaceutical and
nutraceutical products derived from decades of research by Dr. Kevin
Buckman. Dr. Buckman has created more than a dozen formulas which are
intended to address some of the nutraceutical needs of individuals
for wellness and health maintenance.
Dr. Buckman has created more than a dozen formulas which are intended
to address the underlying needs of individuals suffering from what he
calls "DDS" (Degenerative Disease Syndrome). This includes such
maladies as gastrointestinal disorders, auto-immune diseases, asthma,
arthritis, diabetes, arthritis, cancer, and heart disease. In
addition, Dr. Buckman describes his "Broadspectrum" health drink as
the "World's Healthiest Drink," in part because it includes nutrients
from the land and sea from around the world, and it is rich in many
nutrients that may be lacking in the modern diet. This is based on
his decades of research in this field.
About Viratech Corp.
Based in Stockton, California, Viratech Corp., which just announced
its acquisition of Cancer.im,
http://www.youtube.com/watch v=dz1tHRb3wvU, has created an open
source biotech research and development platform. Viratech has
created a unique platform leveraging the utility of social
collaboration, which will allow cancer research the opportunity for
the first time to become open sourced. This is accomplished by
allowing our development partners the ability to protect, promote and
produce their research in unified online collaboration hubs known as
micro social networks. Viratech's open source platform has integrated
several intellectual property tools which, by leveraging our social
collaboration network, can give our development partners a new
intellectual property mechanism, which will help in addressing the
protection of Intellectual Property, promotion through collaboration
in our protected open source platform, and commercial development of
the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual
property, then use Viratech's micro social network as a utility to
promote and crowdfund the research and development to produce the new
Kevin Buckman MD
Email Contact: Email Contact
Tel: 209 477 3030
SOURCE: Viratech Corp.
[ Back To Financial Technology's Homepage ]